Abionic

Abionic

Lab-quality results within minutes, at the point-of-care!

Founded 2010

Epalinges, Switzerland 28 employees Grant Total: $26.61M Biotechnology, Health Care +2

Abionic is an in vitro diagnostics (IVD) company that was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL). The company's slogan, "Immediate clinical decision-making at your fingertip," encapsulates its mission to revolutionize patient care through cutting-edge nanofluidic technology. Abionic's ultra-rapid diagnostic platform is designed to empower healthcare professionals to make clinical decisions at the point of care. With a focus on Biotechnology, Health Care, and Pharmaceutical industries, Abionic is positioned to make significant contributions to the healthcare sector. The company is headquartered in Switzerland, a hub of innovation in the life sciences industry. In its most recent funding round, Abionic secured a Fr.75.00K grant investment from Swiss Medtech on 13 June 2023. This investment signifies confidence from a notable player in the Swiss medical technology sector and demonstrates the potential for Abionic's technology to make a meaningful impact in the field of diagnostics. Overall, Abionic's focus on rapidly transforming diagnostic capabilities and its backing by respected investors position it as an exciting player in the healthcare technology landscape, poised for future growth and impact.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	Fr.75.00K	1	Swiss Medtech	13 Jun 2023
Series C	Fr.20.00M	9	3wVentures, Verve Ventures +7	28 Mar 2018
Series B	Fr.3.80M	2	BlueOcean Ventures, MedHoldings	14 Oct 2014
Debt Financing	Fr.500.00K	1	Foundation for Technological Innovation (FIT)	30 Oct 2013
Series A	Fr.2.00M	5	Polytech Ventures, BlueOcean Ventures +3	26 Apr 2012
Debt Financing	Fr.100.00K	1	Foundation for Technological Innovation (FIT)	09 Dec 2010
Pre Seed Round	Fr.100.00K	1	Venture Kick	03 Nov 2010
Grant	Fr.20.00K	1	Venture Kick	23 Jun 2010
Grant	Fr.10.00K	1	Venture Kick	13 Apr 2010

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

Fr.75.00K

Swiss Medtech

13 Jun 2023

Series C

Fr.20.00M

3wVentures, Verve Ventures +7

28 Mar 2018

Series B

Fr.3.80M

BlueOcean Ventures, MedHoldings

14 Oct 2014

Debt Financing

Fr.500.00K

Foundation for Technological Innovation (FIT)

30 Oct 2013

Series A

Fr.2.00M

Polytech Ventures, BlueOcean Ventures +3

26 Apr 2012

Debt Financing

Fr.100.00K

Foundation for Technological Innovation (FIT)

09 Dec 2010

Pre Seed Round

Fr.100.00K

Venture Kick

03 Nov 2010

Grant

Fr.20.00K

Venture Kick

23 Jun 2010

Grant

Fr.10.00K

Venture Kick

13 Apr 2010

FAQ About Abionic

Lab-quality results within minutes, at the point-of-care!

Abionic was founded in 2010.

Abionic is headquartered in Epalinges, Switzerland.

Abionic operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on In Vitro Diagnostics, Nanofluidics, Biomedical Optics and Point-of-Care Testing.

Abionic has approximately 28 employees.

Abionic has completed 9 funding rounds, raising a total of $26.61M. The latest funding stage is Grant.

Top alternatives and competitors to Abionic include Photoderma, FRIZ Biochem GmbH, Hememics Biotechnologies, Inc., HemoSonics, Rheonix, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Abionic and Photoderma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Abionic

Funding Rounds & Investors (9)

Abionic Alternatives & Competitors

FAQ About Abionic